Cam Gallagher, President at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 19,428 shares at $22.22 ($432K) on 2023-02-06, disclosed to the SEC on 2023-02-06.
Open-market sale of $432k ZNTL by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.22 | 9,428 | $209K | 48.5% |
| 2 | $22.22 | 9,428 | $209K | 48.5% |
| 3 | $23.04 | 572 | $13K | 3.0% |
| Total | $22.24 avg | 19,428 | $432K | 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |